Medication info
Korea Candesartan Tablets 16 Milligrams (Candesartan Cilexetil)

Korea Candesartan Tablets 16 Milligrams (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Korea Pharmaceutical Co., Ltd.
Appearance
Pink, round tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 200908367 · Approved 2009.11.30 · Insurance code 642802320

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
Take this medication at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is candesartan cilexetil 8 ∼ 16 mg orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Older adults: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild or moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Older adults, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension Adolescents and children aged 18 years or younger: Safety and efficacy have not been established. 2. Heart failure Adolescents and children aged 18 years or younger: Safety and efficacy have not been established.

Ingredients

Manufacturer
Korea Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular systolic function
  • decreased left ventricular ejection fraction
View approved original text

This medication is used to control blood pressure in patients with essential hypertension and is indicated for patients with heart failure and impaired left ventricular systolic function, especially those who are classified as NYHA class II to IV and have a left ventricular ejection fraction of 40% or less, requiring additional treatment or who are intolerant to ACE inhibitors. This helps alleviate heart failure symptoms and improve cardiac function.

How to take

Adult dose

Take this medication at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is candesartan cilexetil 8 ∼ 16 mg orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Older adults: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild or moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Older adults, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension Adolescents and children aged 18 years or younger: Safety and efficacy have not been established. 2. Heart failure Adolescents and children aged 18 years or younger: Safety and efficacy have not been established.

Precautions

This drug can cause serious harm to the fetus and newborn if taken during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Women who are pregnant or breastfeeding should not use this drug, and especially women who may become pregnant should consult a doctor before taking it. Persons with allergies to this drug or its components, severe liver disease, cholestasis, or a history of angioedema should not take it. Additionally, those with genetic lactose intolerance should also avoid this medication. Elderly patients, patients with hyperkalemia, those with impaired liver function, and patients with heart valve disease should use this drug cautiously, ensuring that blood pressure does not fall too low. Patients with impaired kidney function or those who have received kidney transplants should regularly monitor kidney function and blood potassium levels while taking this medication. This drug may cause side effects such as dizziness, back pain, and respiratory infections, and rarely severe side effects such as blood abnormalities, liver dysfunction, skin rashes, and muscle pain may occur. If side effects occur, notify healthcare personnel immediately and seek appropriate measures. This drug may lead to dangerously low blood pressure or dangerously high potassium levels when taken with other antihypertensives or potassium-sparing diuretics, so caution is necessary. Particularly, when taken with non-steroidal anti-inflammatory drugs, there is a risk of worsening kidney function, so consultation with a physician is advised. When undergoing surgery or anesthesia, it is essential to inform healthcare personnel about taking this drug, and it is recommended to avoid taking it within 24 hours prior to surgery. Caution should be exercised to prevent accidents due to dizziness or drowsiness when driving or operating machinery after taking this medication. The safety and effectiveness of this drug have not been established in children and adolescents, so its use is not recommended. In case of overdose, blood pressure may drop sharply, so visit a medical institution immediately for appropriate treatment. Finally, this medication should be stored out of reach of children and not transferred to other containers for safety.

Side effects

  • Dizziness
  • back pain
  • respiratory infection
  • fatigue
  • fever
  • sensory disturbances
  • indigestion
  • gastroenteritis
  • tachycardia
  • palpitations
Show 63 more
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • renal impairment
  • increased creatinine
  • elevated urea
  • fatigue
  • peripheral edema
  • chest pain
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • intestinal vascular edema
  • increased liver enzyme levels
  • hepatitis
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial swelling
  • thirst
  • sleep disturbance
  • decreased libido
  • memory loss
  • decrease in appetite
  • increase in appetite
  • tinnitus
  • dysgeusia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and humidity, so it should always be stored in a tightly sealed container. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help safely maintain the drug's effectiveness.

Appearance and packaging

Appearance

Pink, round tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.